Your Paper Your Way
We now differentiate between the requirements for new and revised submissions. You may choose to submit your manuscript as a single Word or PDF file to be used in the refereeing process. Only when your paper is at the revision stage, will you be requested to put your paper in to a 'correct format' for acceptance and provide the items required for the publication of your article.
To find out more, please visit the Preparation section below.
Categories of manuscripts
Brief Articles. Reserved for cutting edge early studies that would highly impact the field. Manuscripts in this category are in the same format as a Regular Article, but are generally less than 20 total manuscript pages in length (double-spaced) and have three or less figures or tables.
Regular Manuscripts. Manuscripts submitted in this category are expected to be concise, well organized, and clearly written. Acceptance is based on originality and importance to the field of blood and marrow transplantation. These manuscripts are reviewed by two or more experts in the field, and detailed comments from the reviewers are generally returned to the authors. Manuscripts requiring extensive revision will be at a disadvantage for publication. Manuscripts are submitted with the understanding that they are original contributions and do not contain data that have been published elsewhere, including symposia volumes, etc. Meeting abstracts do not constitute prior publication.Rapid Communications. Definitive papers of exceptional scientific importance within the discipline of blood and marrow transplantation will be considered for expedited review and publication. Consideration as a Rapid Communication must be requested at the time of submission by the authors and requires approval by the Editorial Board. Papers that the Editors decide not to process as Rapid Communications will be handled as regular manuscripts unless the authors choose to have them returned without further review. Criteria for selection as Rapid Communications include originality, importance, and the potential value of accelerated publication to the readers of Biology of Blood and Marrow Transplantation. Decisions on these manuscripts will be made within four weeks of receipt and in general will not be accompanied by detailed reviewers' comments. Although there is no page limit for manuscripts in this category, clear and concise presentation of data is required. Manuscripts requiring extensive revisions or editing will be at a disadvantage for publication in this category. Case reports, methods papers, or preliminary studies should not be submitted for consideration as Rapid Communications.
Review Articles. Review articles on topics of broad interest are highly desired and may be solicited by the Editor-in-Chief. Individuals who wish to write a review article should correspond with the Editor in Chief regarding the appropriateness of the proposed topic. Such articles are expected to be thorough and detailed and should include appropriate references to the literature. The addition of tables and figures to summarize critical points is encouraged. These articles are reviewed by the Editors and other expert reviewers before a final decision regarding publication is made, and revisions may be required. Review articles should be limited to no more than 5,000 words (exclusive of references)and no more than 80 references.Clinical Reviews. Short, highly focused articles that review topics related to therapy, diagnosis, or other clinical issues in hematology may be published as Clinical Reviews. Authors who wish to write a Clinical Review should correspond with the Editor in Chief regarding the proposed topic. Such manuscripts will be reviewed by expert reviewers and will be accepted for publication based on their educational value and clarity. Manuscript submission fees and page charges are not assessed on review articles.
Editorials. Concise, invited commentaries on articles published in Biology of Blood and Marrow Transplantation or other topics in hematology are highly desired.Letters. Letters to the Editor commenting on articles published in Biology of Blood and Marrow Transplantation are welcomed. Letters should be as concise as possible (no more than three double-spaced pages), include no more than 10 references,
Case Reports are not published in BBMT, and will not be accepted in any format. Ethics in publishing
For information on Ethics in publishing and Ethical guidelines for journal publication see http://www.elsevier.com/publishingethics and http://www.elsevier.com/journal-authors/ethics.
Biology of Blood and Marrow Transplantation considers research and publication misconduct to be a serious breach of ethics, and will take such actions as necessary to address such misconduct. Authors should refer to the Committee on Publication Ethics (COPE) and the International Committee of Medical Journal Editors for full information. Authors are also encouraged to visit Elsevier's Ethical Guidelines for Journal Publication.
Conflict of interest
All authors must disclose any financial and personal relationships with other people or organizations that could inappropriately influence (bias) their work. Examples of potential conflicts of interest include employment, consultancies, stock ownership, honoraria, paid expert testimony, patent applications/registrations, and grants or other funding. If there are no conflicts of interest then please state this: 'Conflicts of interest: none'. See also http://www.elsevier.com/conflictsofinterest. Further information and an example of a Conflict of Interest form can be found at: http://service.elsevier.com/app/answers/detail/a_id/286/supporthub/publishing.
Submission of an article implies that the work described has not been published previously (except in the form of an abstract or as part of a published lecture or academic thesis or as an electronic preprint, see http://www.elsevier.com/sharingpolicy), that it is not under consideration for publication elsewhere, that its publication is approved by all authors and tacitly or explicitly by the responsible authorities where the work was carried out, and that, if accepted, it will not be published elsewhere in the same form, in English or in any other language, including electronically without the written consent of the copyright-holder. To verify originality, your article may be checked by the originality detection service CrossCheck http://www.elsevier.com/editors/plagdetect.
All material in Biology of Blood and Marrow Transplantation represents the opinions of the authors and does not reflect the opinions of the American Society for Blood and Marrow Transplantation (ASBMT), Elsevier Inc., or the institutions with which the authors are affiliated. Authors submitting manuscripts do so with the understanding that, if accepted, copyright in the article, including the right to reproduce the article in all forms and media including electronic media, shall be assigned exclusively to the ASBMT and authors will be requested to sign a copyright release form.
Upon acceptance of an article, authors will be asked to complete a 'Journal Publishing Agreement' (for more information on this and copyright, see http://www.elsevier.com/copyright). An e-mail will be sent to the corresponding author confirming receipt of the manuscript together with a 'Journal Publishing Agreement' form or a link to the online version of this agreement.
Subscribers may reproduce tables of contents or prepare lists of articles including abstracts for internal circulation within their institutions. Permission of the Publisher is required for resale or distribution outside the institution and for all other derivative works, including compilations and translations (please consult http://www.elsevier.com/permissions). If excerpts from other copyrighted works are included, the author(s) must obtain written permission from the copyright owners and credit the source(s) in the article. Elsevier has preprinted forms for use by authors in these cases: please consult http://www.elsevier.com/permissions.Author rights
As an author you (or your employer or institution) have certain rights to reuse your work. For more information see http://www.elsevier.com/copyright.
NIH Public Access Policy Compliance
To comply with the NIH Public Access Policy, Elsevier will deposit to PubMed Central (PMC) author manuscripts on behalf of authors reporting NIH funded research. The NIH policy requires that NIH-funded authors submit to PubMed Central (PMC), or have submitted on their behalf, their peer-reviewed author manuscripts, to appear on PMC no later than 12 months after final publication. Elsevier will send to PMC the final peer-reviewed manuscript, which was accepted for publication and sent to Elsevier's production department, and that reflects any author-agreed changes made in response to peer-review comments. Elsevier will authorize the author manuscript's public access posting 12 months after final publication. Following the deposit by Elsevier, authors will receive further communications from the NIH with respect to the submission.
Other Funding Body PoliciesElsevier has also worked with the following funding bodies to ensure that our authors can comply with their policies:
- Arthritis Research Campaign (UK)- British Heart Foundation (UK)
- Cancer Research (UK)- Chief Scientist Office
- Department of Health (UK)- Howard Hughes Medical Institute (US)
- Medical Research Council (UK)- Wellcome Trust (UK)
For full details on how these policies are implemented, please see complete information at: http://www.elsevier.com/fundingbodyagreementsFunding body agreements and policies
Elsevier has established a number of agreements with funding bodies which allow authors to comply with their funder's open access policies. Some authors may also be reimbursed for associated publication fees. To learn more about existing agreements please visit http://www.elsevier.com/fundingbodies.
After acceptance, open access papers will be published under a noncommercial license. For authors requiring a commercial CC BY license, you can apply after your manuscript is accepted for publication.
• Articles are freely available to both subscribers and the wider public with permitted reuse
• An open access publication fee is payable by authors or on their behalf e.g. by their research funder or institution
• Articles are made available to subscribers as well as developing countries and patient groups through our universal access programs (http://www.elsevier.com/access).
• No open access publication fee payable by authors.
Regardless of how you choose to publish your article, the journal will apply the same peer review criteria and acceptance standards.For open access articles, permitted third party (re)use is defined by the following Creative Commons user licenses:
Creative Commons Attribution-NonCommercial-NoDerivs (CC BY-NC-ND)
For non-commercial purposes, lets others distribute and copy the article, and to include in a collective work (such as an anthology), as long as they credit the author(s) and provided they do not alter or modify the article.
The open access publication fee for this journal is USD 3000, excluding taxes. There is a 10% discount off the open access publication fee for members of the American Society for Blood and Marrow Transplantation. Learn more about Elsevier's pricing policy: http://www.elsevier.com/openaccesspricing.
Authors can share their research in a variety of different ways and Elsevier has a number of green open access options available. We recommend authors see our green open access page for further information (http://elsevier.com/greenopenaccess). Authors can also self-archive their manuscripts immediately and enable public access from their institution's repository after an embargo period. This is the version that has been accepted for publication and which typically includes author-incorporated changes suggested during submission, peer review and in editor-author communications. Embargo period: For subscription articles, an appropriate amount of time is needed for journals to deliver value to subscribing customers before an article becomes freely available to the public. This is the embargo period and begins from the publication date of the issue your article appears in.
This journal has an embargo period of 12 months.
Manuscript Submission and Handling
Biology of Blood and Marrow Transplantation utilizes a web-based manuscript submission and peer-review system. Authors should submit their manuscripts, with figures and tables, electronically at the journal Web site, www.bbmt.org. Authors can also visit External link http://ees.elsevier.com/ybbmt. Complete instructions are available at the Web site. If authors experience any difficulty during the submission process or require any assistance, they should visit External link http://support.elsevier.com. If authors do not receive an e-mail confirmation of submission within 24 hours, it may be an indication that the manuscript has not been received by the editorial office. In this instance, authors should contact the editorial office (Robert Korngold, PhD, Hackensack University Medical Center, 40 Prospect Avenue – Rm 356 Jurist Research Building, Hackensack, NJ 07601; Tel: (551) 996-8664; Fax: (551) 996-8696; E-mail: RKorngold@HackensackUMC.org).
Please submit your article via http://support.elsevier.com.
Submission to this journal proceeds totally online and you will be guided stepwise through the creation and uploading of your files. The system automatically converts your files to a single PDF file, which is used in the peer-review process.
As part of the Your Paper Your Way service, you may choose to submit your manuscript as a single file to be used in the refereeing process. This can be a PDF file or a Word document, in any format or lay-out that can be used by referees to evaluate your manuscript. It should contain high enough quality figures for refereeing. If you prefer to do so, you may still provide all or some of the source files at the initial submission. Please note that individual figure files larger than 10 MB must be uploaded separately.
There are no strict requirements on reference formatting at submission. References can be in any style or format as long as the style is consistent. Where applicable, author(s) name(s), journal title/book title, chapter title/article title, year of publication, volume number/book chapter and the pagination must be present. Use of DOI is highly encouraged. The reference style used by the journal will be applied to the accepted article by Elsevier at the proof stage. Note that missing data will be highlighted at proof stage for the author to correct.
There are no strict formatting requirements but all manuscripts must contain the essential elements needed to convey your manuscript, for example Abstract, Keywords, Introduction, Materials and Methods, Results, Conclusions, Artwork and Tables with Captions.
If your article includes any Videos and/or other Supplementary material, this should be included in your initial submission for peer review purposes.
Divide the article into clearly defined sections.
Please ensure the figures and the tables included in the single file are placed next to the relevant text in the manuscript, rather than at the bottom or the top of the file. Use of word processing software
Regardless of the file format of the original submission, at revision you must provide us with an editable file of the entire article. Keep the layout of the text as simple as possible. Most formatting codes will be removed and replaced on processing the article. The electronic text should be prepared in a way very similar to that of conventional manuscripts (see also the Guide to Publishing with Elsevier: http://www.elsevier.com/guidepublication). See also the section on Electronic artwork.
To avoid unnecessary errors you are strongly advised to use the 'spell-check' and 'grammar-check' functions of your word processor.
Organization of the Manuscript
Organize submitted manuscripts as follows: Cover Letter, Title Page (including title; authors' full names, academic degrees, and affiliations; corresponding author's address, phone number, fax number, and e-mail address; and a short title), Financial Disclosure Statement, Abstract, Introduction, Materials and Methods, Results, Discussion, Acknowledgments, References, Tables, Figure Legends, and Figures. Manuscripts should be double-spaced and formatted for standard paper with 1-inch margins.
Although a graphical abstract is optional, its use is encouraged as it draws more attention to the online article. The graphical abstract should summarize the contents of the article in a concise, pictorial form designed to capture the attention of a wide readership. Graphical abstracts should be submitted as a separate file in the online submission system. Image size: Please provide an image with a minimum of 531 × 1328 pixels (h × w) or proportionally more. The image should be readable at a size of 5 × 13 cm using a regular screen resolution of 96 dpi. Preferred file types: TIFF, EPS, PDF or MS Office files. See http://www.elsevier.com/graphicalabstracts for examples.
Authors can make use of Elsevier's Illustration and Enhancement service to ensure the best presentation of their images and in accordance with all technical requirements: Illustration Service.
Highlights are mandatory for this journal. They consist of a short collection of bullet points that convey the core findings of the article and should be submitted in a separate editable file in the online submission system. Please use 'Highlights' in the file name and include 3 to 5 bullet points (maximum 85 characters, including spaces, per bullet point). See http://www.elsevier.com/highlights for examples.
Abbreviations should be defined at their first use and applied consistently throughout the article. Do not use nonstandard abbreviations or abbreviate terms appearing fewer than three times. Give the chemical name of a compound after the first use of the trivial name. The trivial name may follow throughout the article.
Authors must disclose any primary financial relationship with a company that has a direct financial interest in the subject matter or products discussed in the submitted manuscript, or with a company that produces a competing product. These relationships (such as honoraria, ownership of stock, patents, or consulting fees) and any direct support of research by a commercial company will be included in the Acknowledgements section of the published article.
Footnotes should be used sparingly. Number them consecutively throughout the article. Many word processors build footnotes into the text, and this feature may be used. Should this not be the case, indicate the position of footnotes in the text and present the footnotes themselves separately at the end of the article.
• Make sure you use uniform lettering and sizing of your original artwork.
• Preferred fonts: Arial (or Helvetica), Times New Roman (or Times), Symbol, Courier.
• Number the illustrations according to their sequence in the text.
• Use a logical naming convention for your artwork files.
• Indicate per figure if it is a single, 1.5 or 2-column fitting image.
• For Word submissions only, you may still provide figures and their captions, and tables within a single file at the revision stage.
• Please note that individual figure files larger than 10 MB must be provided in separate source files.
A detailed guide on electronic artwork is available on our website:
You are urged to visit this site; some excerpts from the detailed information are given here.
Regardless of the application used, when your electronic artwork is finalized, please 'save as' or convert the images to one of the following formats (note the resolution requirements for line drawings, halftones, and line/halftone combinations given below):
EPS (or PDF): Vector drawings. Embed the font or save the text as 'graphics'.
TIFF (or JPG): Color or grayscale photographs (halftones): always use a minimum of 300 dpi.
TIFF (or JPG): Bitmapped line drawings: use a minimum of 1000 dpi.
TIFF (or JPG): Combinations bitmapped line/half-tone (color or grayscale): a minimum of 500 dpi is required.
Please do not:
• Supply files that are optimized for screen use (e.g., GIF, BMP, PICT, WPG); the resolution is too low.
• Supply files that are too low in resolution.
• Submit graphics that are disproportionately large for the content.
Part of the cost of publishing color photographs will be borne by the authors and payment must be made to the publisher prior to publication. The cost to publish color figures in print is $500 for the first color figure and $100 for each additional color figure.
Figures and Figure Legends
Figures must be cited in the text in numerical order using Arabic numerals. Figures should be generated in .tif format; see instructions on Web site. Figure legends should be double-spaced on a separate page and should include a brief title and a concise explanation of each figure.
Ensure that each illustration has a caption. A caption should comprise a brief title (not on the figure itself) and a description of the illustration. Keep text in the illustrations themselves to a minimum but explain all symbols and abbreviations used.
Each table should be printed or typed on a separate page, appropriately numbered and cited in numerical order in the text. Legends giving sufficient explanation to make the data intelligible without reference to the text must be typed on the same page.
Include double-spaced references in numerical order at the end of the article according to the order of citation in the text. The names of all authors should be given unless there are more than 6, in which case the names of the first 3 authors should be given, followed by "et al." Abbreviate the names of journals according to the abbreviations used in the latest edition of Index Medicus, Superintendent of Documents, US Government Printing Office, Washington, DC 20402. References to abstracts and letters must be appropriately identified. References to personal communications, unpublished observations, and manuscripts submitted and "in preparation" must appear parenthetically in the text.
Please use the following form for references:9. Singer JW, Charbord P, Keating A, et al. Simian virus 40-transformed adherent cells from human long-term marrow cultures: cloned cell lines produce cells with stromal and hematopoietic characteristics. Biol Blood Marrow Transplant. 1995;7:464-469.
10. Cone RD, Williams DA, Davies TF. Establishment of differentiated cell lines using oncogene-containing retroviral vectors. In: Glunzman Y, Hughes SH, eds. Viral Vectors. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press; 1993:34-39.Reference links
Increased discoverability of research and high quality peer review are ensured by online links to the sources cited. In order to allow us to create links to abstracting and indexing services, such as Scopus, CrossRef and PubMed, please ensure that data provided in the references are correct. Please note that incorrect surnames, journal/book titles, publication year and pagination may prevent link creation. When copying references, please be careful as they may already contain errors. Use of the DOI is encouraged.
Reference management software
Most Elsevier journals have a standard template available in key reference management packages. This covers packages using the Citation Style Language, such as Mendeley (http://www.mendeley.com/features/reference-manager) and also others like EndNote (http://www.endnote.com/support/enstyles.asp) and Reference Manager (http://refman.com/downloads/styles). Using plug-ins to word processing packages which are available from the above sites, authors only need to select the appropriate journal template when preparing their article and the list of references and citations to these will be formatted according to the journal style as described in this Guide. The process of including templates in these packages is constantly ongoing. If the journal you are looking for does not have a template available yet, please see the list of sample references and citations provided in this Guide to help you format these according to the journal style.
If you manage your research with Mendeley Desktop, you can easily install the reference style for this journal by clicking the link below:
When preparing your manuscript, you will then be able to select this style using the Mendeley plug-ins for Microsoft Word or LibreOffice. For more information about the Citation Style Language, visit http://citationstyles.org.
There are no strict requirements on reference formatting at submission. References can be in any style or format as long as the style is consistent. Where applicable, author(s) name(s), journal title/book title, chapter title/article title, year of publication, volume number/book chapter and the pagination must be present. Use of DOI is highly encouraged. The reference style used by the journal will be applied to the accepted article by Elsevier at the proof stage. Note that missing data will be highlighted at proof stage for the author to correct. If you do wish to format the references yourself they should be arranged according to the following examples:
Supplementary Material for Online Publication
In cases where essential information associated with an article is too extensive for print publication (e.g., data sets, additional figures, video files), this content can be included as online-only supplemental information. Supplementary material file(s) should be provided at the time of manuscript submission, and should be called out in the text (egg, Table S2, Fig S1, Item S4). Titles and/or legends for each supplementary figure or item should be included as the final page of the manuscript document. Unless otherwise requested, supplementary material will generally be corrected for style, grammar, and format.
The following list will be useful during the final checking of an article prior to sending it to the journal for review. Please consult this Guide for Authors for further details of any item.
Ensure that the following items are present:
One author has been designated as the corresponding author with contact details:
• E-mail address
• Full postal address
All necessary files have been uploaded, and contain:
• All figure captions
• All tables (including title, description, footnotes)
• Manuscript has been 'spell-checked' and 'grammar-checked'
• All references mentioned in the Reference list are cited in the text, and vice versa
• Permission has been obtained for use of copyrighted material from other sources (including the Internet)
Printed version of figures (if applicable) in color or black-and-white
• Indicate clearly whether or not color or black-and-white in print is required.
For any further information please visit our customer support site at http://support.elsevier.com.
Authors of accepted manuscripts will receive galley proofs as pdf files via e-mail directly from the publisher and are responsible for proofreading. Except for correcting typesetting errors, authors may be charged for extensive alterations. Corrections should be returned within 48 hours to avoid delay in publication.
The corresponding author, at no cost, will be provided with a personalized link providing 50 days free access to the final published version of the article on ScienceDirect. This link can also be used for sharing via email and social networks. For an extra charge, paper offprints can be ordered via the offprint order form which is sent once the article is accepted for publication. Both corresponding and co-authors may order offprints at any time via Elsevier's WebShop (http://webshop.elsevier.com/myarticleservices/offprints). Authors requiring printed copies of multiple articles may use Elsevier WebShop's 'Create Your Own Book' service to collate multiple articles within a single cover (http://webshop.elsevier.com/myarticleservices/booklets).
Reprints must be ordered and paid for in advance. An order form with the cost of reprints and instructions for payment will be sent directly from the publisher with page proofs. Reprint orders, payments, and inquiries should be directed to Elsevier.
Announcements of meetings that are of interest to the readers of Biology of Blood and Marrow Transplantation should be sent to the Editor at least three months before the first day of the month of issue. Fees for announcements vary depending on their size and number of insertions; please call the Editorial Office for details. Publisher Contact Information:
360 Park Avenue South, New York, NY 10010-1710T: +1.212.462.1918 M: +firstname.lastname@example.org